[1]马玉珍,毛德文,覃艳新,等.六味醒神颗粒治疗肝硬化轻微型肝性脑病的临床疗效及其对血氨和内毒素的影响[J].西部中医药,2021,34(05):7-10.[doi:10.12174/j.issn.2096-9600.2021.05.03]
　MA Yuzhen,MAO Dewen,QIN Yanxin,et al.Clinical Effects of Liuwei Xingshen Granules in Treating Mild Hepatic Encephalopathy of Liver Cirrhosis and Its Influence on Blood Ammonia and Endotoxin[J].Western Journal of Traditional Chinese Medicine,2021,34(05):7-10.[doi:10.12174/j.issn.2096-9600.2021.05.03]
点击复制

六味醒神颗粒治疗肝硬化轻微型肝性脑病的临床疗效及其对血氨和内毒素的影响
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
34
期数:
2021年05期
页码:
7-10
栏目:
临床论著
出版日期:
2021-05-15

文章信息/Info

Title:
Clinical Effects of Liuwei Xingshen Granules in Treating Mild Hepatic Encephalopathy of Liver Cirrhosis and Its Influence on Blood Ammonia and Endotoxin
作者:
马玉珍1, 毛德文2, 覃艳新1, 莫镜鄰1, 王明刚2
1.广西中医药大学，广西 南宁 530001
2.广西中医药大学第一附属医院
Author(s):
MA Yuzhen1, MAO Dewen2, QIN Yanxin1, MO Jingling1, WANG Minggang2
1.Guangxi University of Chinese Medicine, Nanning 530001, China
2.The First Affiliated Hospital of Guangxi University of Chinese Medicine
关键词:
肝硬化; 肝性脑病; 轻微型; 血氨; 内毒素; 六味醒神颗粒
Keywords:
liver cirrhosis; hepatic encephalopathy;  mild; plasma ammonia; endotoxin; granules
分类号:
R243
DOI:
10.12174/j.issn.2096-9600.2021.05.03
摘要:
目的观察六味醒神颗粒治疗肝硬化轻微型肝性脑病（minimal hepatic encephalopathy，MHE）的临床疗效及其对血氨、内毒素的影响。 方法将肝硬化MHE患者52例按照随机数字表法分为两组各26例。对照组予常规支持治疗，治疗组在对照组基础上加用六味醒神颗粒。治疗2周后统计临床疗效，检测两组治疗前后肝功能［谷丙转氨酶（alanine transaminase，ALT）、总胆红素（total bilirubin，TBIL）］、血氨及内毒素水平，计算数字连接试验A(number connection test,NCT-A)、数字符号试验(digital symbol test,DST)评分。 结果治疗2周后两组患者肝功能（ALT、TBIL）、血氨及内毒素水平较治疗前降低，差异有统计学意义（P＜0.05），且治疗组低于对照组（P＜0.05）。治疗后两组患者NCT-A时间均较治疗前缩短（P＜0.05），且治疗组短于对照组（P＜0.05）。治疗后两组患者DST评分均较治疗前升高（P＜0.05），且治疗组高于对照组（P＜0.05）。治疗组总有效率为92.3%（24/26），高于对照组的76.0%（19/25）（P＜0.05）。 结论六味醒神颗粒能降低肝硬化MHE患者血氨、内毒素水平，能提高患者集中注意能力、精神运动反应速度、精神运动的准确性等，进而改善患者认知功能。
Abstract:
ObjectiveTo observe clinical effects of Liuwei Xingshen granules in the treatment of MHE of liver cirrhosis and its influence on blood ammonia and endotoxin. MethodsAll 52 MHE patients were allocated to two groups in light of random number table method, 26 cases in each group. The control group accepted conventional supportive treatment, the treatment group took Liuwei Xingshen granules based on conventional supportive treatment, after two weeks of treatment, to analyze clinical effects, to detect the levels of liver function (ALT and TBIL), plasma ammonia and endotoxin before and after treating in two groups, to calculate the scores of NCT-A and DST. ResultsAfter two weeks of treatment, the levels of liver function (ALT and TBIL), plasma ammonia and endotoxin in both groups were lower than these before treating, and the difference was statistically significant (P<0.05), and the treatment group was lower than the control group (P<0.05). After treating, NCT-A time of both groups reduced compared with that before treating (P<0.05). and the treatment group was less than the control group (P<0.05). After treating, DST scores of both groups rose than these before treating (P<0.05), and the treatment group was higher than the control group (P<0.05). Total effective rate of the treatment group was 92.3%(24/26), higher than 76.0%(19/25) of the control group (P<0.05). ConclusionLiuwei Xingshen granules could reduce the levels of plasma ammonia and endotoxin, raise cognitive flexibility, the patients’ ability of focusing their attention, psychomotor reaction speed, psychomotor accuracy and others, thus improve their cognitive function.

相似文献/References:

[1]黄鸿娜,黄晶晶△,王振常,等.柔肝化纤颗粒治疗肝硬化脾功能亢进症的临床观察[J].西部中医药,2014,27(09):111.
[2]张萍,朱建坤.肝硬化患者应用中医食疗的临床护理分析[J].西部中医药,2013,26(07):112.
　ZHANG Ping,ZHU Jiankun.Analysis on Clinical Nursing for Liver Cirrhosis Patients Given with TCM Food Therapy[J].Western Journal of Traditional Chinese Medicine,2013,26(05):112.
[3]刘建军,曾贤翠,郝淑萍,等.腹水超滤浓缩回输联合中医辨证治疗肝硬化顽固性腹水40例临床观察[J].西部中医药,2013,26(06):1.
　LIUJianjun,ZENGXiancui,HAOShuping,et al.ClinicalObservationonUltrafiltrationReinfusionofConcentratedAscitesandSyndromeDifferentiationforRefractoryAscitesofLiverCirrhosis:AReportof40Cases[J].Western Journal of Traditional Chinese Medicine,2013,26(05):1.
[4]樊红,冯彦虎,张德奎△,等.中西医结合治疗肝炎后肝硬化腹水疗效观察[J].西部中医药,2013,26(02):91.
　FAN Hong,FENG Yanhu,ZHANG Dekui,et al.Clinical Observation on Integrative Medicine in Treating Cirrhosis Ascites of Patients with Hepatitis[J].Western Journal of Traditional Chinese Medicine,2013,26(05):91.
[5]闫雪华.恩替卡韦联合复方鳖甲软肝片治疗代偿期乙肝肝硬化疗效观察[J].西部中医药,2014,27(07):84.
　YAN Xuehua.Clinical Observation on Entecavir Combined with Compound BieJia RuanGan Tablets in Treating Decompensated Liver Cirrhosis of Hepatitis B[J].Western Journal of Traditional Chinese Medicine,2014,27(05):84.
[6]龚红霞,邱晶.多层螺旋CT门静脉成像在肝硬化中医证型诊断中的应用价值[J].西部中医药,2018,31(12):147.
　GONG Hongxia,QIU Jing.Application Value of Multilayer Spiral CT Portal Vein Imaging in the Diagnosis of TCM Patterns of Liver Cirrhosis[J].Western Journal of Traditional Chinese Medicine,2018,31(05):147.
[7]朱艳国,朱艳丽△,张金花.自拟化积膏治疗肝硬化疗效观察[J].西部中医药,2019,32(05):63.
　ZHU Yanguo,ZHU Yanli,ZHANG Jinhua.Clinical Observation on Selfmade HuaJi Ointment in Treating Cirrhosis[J].Western Journal of Traditional Chinese Medicine,2019,32(05):63.
[8]陈美岑,等.柔肝化纤颗粒对失代偿期肝硬化患者肠道菌群的影响[J].西部中医药,2021,34(12):99.[doi:10.12174/j.issn.2096-9600.2021.12.26]
　CHEN Meicen,WANG Zhenchang,et al.Effects of Rougan Huaxian Granules on Intestinal Flora in Patients with Decompensated Cirrhosis[J].Western Journal of Traditional Chinese Medicine,2021,34(05):99.[doi:10.12174/j.issn.2096-9600.2021.12.26]
[9]徐婷婷,安振涛,李慧,等.肝硬化腹水证治分布及脐敷疗法用药规律文献研究[J].西部中医药,2021,34(06):85.[doi:10.12174/j.issn.2096-9600.2021.06.20]
　XU Tingting,AN Zhentao,LI Hui,et al.Literature Study on the Distribution of Syndrome Differentiation and Treatment of Cirrhosis Ascites and Medication Rules of Umbilical Compressing Therapy[J].Western Journal of Traditional Chinese Medicine,2021,34(05):85.[doi:10.12174/j.issn.2096-9600.2021.06.20]
[10]吴铁雄,刘旭东,朱沪敏,等.大黄?虫胶囊联合心得安治疗乙肝肝硬化门脉高压症临床观察[J].西部中医药,2023,36(02):102.[doi:10.12174/j.issn.2096-9600.2023.02.23]
　WU Tiexiong,LIU Xudong,ZHU Humin,et al.Clinical Observation on Dahuang Zhechong Capsules and Propranolol in the Treatment of Portal Hypertension of Hepatitis B Cirrhosis[J].Western Journal of Traditional Chinese Medicine,2023,36(05):102.[doi:10.12174/j.issn.2096-9600.2023.02.23]

备注/Memo

备注/Memo:
马玉珍（1993—），女，在读硕士研究生。研究方向：肝病的中医药诊治。国家自然科学基金（81774236）；广西科学研究与技术开发计划项目（桂科攻0718002-2）；校级课题（YCSY201900105）。
更新日期/Last Update: 2021-05-15